TREATMENT OF CNS DISORDERS WITH SLEEP DISTURBANCES

A compound for use in the treatment of CNS disorders with sleep disturbances e.g. narcolepsy or Angelman syndrome in a subject, wherein said compound is according to formula (I) or any isomer, tautomer, enantiomer, racemic form or deuterated form thereof, or a pharmaceutically acceptable salt thereo...

Full description

Saved in:
Bibliographic Details
Main Authors KORNUM BIRGITTE RAHBEK, WELLENDORPH PETRINE, FROELUND BENTE
Format Patent
LanguageChinese
English
Published 01.02.2022
Subjects
ACYCLIC OR CARBOCYCLIC COMPOUNDS
CHEMISTRY
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
ORGANIC CHEMISTRY
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Online AccessGet full text

Cover

More Information
Summary:A compound for use in the treatment of CNS disorders with sleep disturbances e.g. narcolepsy or Angelman syndrome in a subject, wherein said compound is according to formula (I) or any isomer, tautomer, enantiomer, racemic form or deuterated form thereof, or a pharmaceutically acceptable salt thereof. 一种用于治疗受试者的伴有睡眠障碍的CNS病症(例如发作性睡病或Angelman综合征)的化合物，其中所述化合物是根据式I或其任何异构体、互变异构体、对映异构体、外消旋形式或氘代形式，或其药学上可接受的盐。
Bibliography:Application Number: CN20208045164